Amphiregulin blockade decreases the levodopa‐induced dyskinesia in a 6‐hydroxydopamine Parkinson's disease mouse model.

MLA

Kambey, Piniel Alphayo, et al. “Amphiregulin Blockade Decreases the Levodopa‐induced Dyskinesia in a 6‐hydroxydopamine Parkinson’s Disease Mouse Model.” CNS Neuroscience & Therapeutics, vol. 29, no. 10, Oct. 2023, pp. 2925–39. EBSCOhost, https://doi.org/10.1111/cns.14229.

APA

Kambey, P. A., Liu, W. Y., Wu, J., Tang, C., Buberwa, W., Saro, A., Nyalali, A. M. K., & Gao, D. (2023). Amphiregulin blockade decreases the levodopa‐induced dyskinesia in a 6‐hydroxydopamine Parkinson’s disease mouse model. CNS Neuroscience & Therapeutics, 29(10), 2925–2939. https://doi.org/10.1111/cns.14229

Chicago

Kambey, Piniel Alphayo, Wen Ya Liu, Jiao Wu, Chuanxi Tang, Wokuheleza Buberwa, Adonira Saro, Alphonce M. K. Nyalali, and Dianshuai Gao. 2023. “Amphiregulin Blockade Decreases the Levodopa‐induced Dyskinesia in a 6‐hydroxydopamine Parkinson’s Disease Mouse Model.” CNS Neuroscience & Therapeutics 29 (10): 2925–39. doi:10.1111/cns.14229.